Creative Planning’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.59M Buy
87,773
+38,948
+80% +$2.34M ﹤0.01% 1275
2025
Q4
$2.87M Buy
48,825
+12,381
+34% +$752K ﹤0.01% 1409
2025
Q3
$2.03M Sell
36,444
-47,013
-56% -$2.52M ﹤0.01% 1534
2025
Q2
$4.29M Buy
83,457
+65,403
+362% +$3.29M ﹤0.01% 834
2025
Q1
$1.06M Sell
18,054
-3,973
-18% -$269K ﹤0.01% 1674
2024
Q4
$1.59M Buy
22,027
+3,514
+19% +$258K ﹤0.01% 1293
2024
Q3
$1.48M Sell
18,513
-15,429
-45% -$1.16M ﹤0.01% 1251
2024
Q2
$2.43M Buy
33,942
+1,437
+4% +$106K ﹤0.01% 908
2024
Q1
$2.29M Buy
32,505
+1,064
+3% +$76.1K ﹤0.01% 918
2023
Q4
$2.43M Buy
31,441
+4,545
+17% +$299K ﹤0.01% 835
2023
Q3
$1.83M Sell
26,896
-149
-0.6% -$11.8K ﹤0.01% 885
2023
Q2
$2.21M Sell
27,045
-1,844
-6% -$148K ﹤0.01% 771
2023
Q1
$2.14M Buy
28,889
+15,188
+111% +$1.17M ﹤0.01% 754
2022
Q4
$1.14M Buy
13,701
+1,901
+16% +$151K ﹤0.01% 978
2022
Q3
$838K Buy
11,800
+8,108
+220% +$701K ﹤0.01% 1039
2022
Q2
$320K Buy
3,692
+528
+17% +$49.5K ﹤0.01% 1566
2022
Q1
$343K Buy
3,164
+356
+13% +$36.7K ﹤0.01% 1542
2021
Q4
$363K Buy
2,808
+248
+10% +$30.4K ﹤0.01% 1493
2021
Q3
$310K Buy
2,560
+32
+1% +$3.89K ﹤0.01% 1574
2021
Q2
$285K Sell
2,528
-1,868
-42% -$197K ﹤0.01% 1594
2021
Q1
$420K Buy
4,396
+316
+8% +$28.8K ﹤0.01% 1558
2020
Q4
$324K Sell
4,080
-1,716
-30% -$124K ﹤0.01% 1573
2020
Q3
$359K Sell
5,796
-940
-14% -$61.1K ﹤0.01% 1310
2020
Q2
$445K Sell
6,736
-276
-4% -$16.5K ﹤0.01% 1092
2020
Q1
$332K Sell
7,012
-116
-2% -$5.8K ﹤0.01% 1135
2019
Q4
$391K Sell
7,128
-104
-1% -$5.46K ﹤0.01% 1247
2019
Q3
$354K Buy
7,232
+92
+1% +$4.61K ﹤0.01% 1264
2019
Q2
$372K Hold
7,140
﹤0.01% 1234
2019
Q1
$354K Buy
7,140
+284
+4% +$12.8K ﹤0.01% 1239
2018
Q4
$248K Sell
6,856
-556
-8% -$23.2K ﹤0.01% 1348
2018
Q3
$378K Buy
7,412
+256
+4% +$11.3K ﹤0.01% 1257
2018
Q2
$265K Hold
7,156
﹤0.01% 1438
2018
Q1
$270K Buy
+7,156
New +$253K ﹤0.01% 1406
2017
Q3
Sell
-4,716
Closed -$139K 3528
2017
Q2
$139K Sell
4,716
-544
-10% -$14.9K ﹤0.01% 1753
2017
Q1
$134K Sell
5,260
-1,256
-19% -$32.4K ﹤0.01% 1767
2016
Q4
$168K Buy
6,516
+248
+4% +$6.52K ﹤0.01% 1506
2016
Q3
$172K Buy
6,268
+148
+2% +$4.07K ﹤0.01% 1486
2016
Q2
$173K Hold
6,120
﹤0.01% 1323
2016
Q1
$145K Sell
6,120
-320
-5% -$7.05K ﹤0.01% 1398
2015
Q4
$145K Sell
6,440
-56
-0.9% -$1.28K ﹤0.01% 1412
2015
Q3
$150K Buy
+6,496
New +$163K ﹤0.01% 1348
2015
Q2
Sell
-6,440
Closed -$161K 2817
2015
Q1
$161K Sell
6,440
-916
-12% -$21.8K ﹤0.01% 1302
2014
Q4
$170K Buy
7,356
+760
+12% +$17.4K ﹤0.01% 1241
2014
Q3
$154K Sell
6,596
-112
-2% -$2.63K ﹤0.01% 1213
2014
Q2
$155K Buy
6,708
+268
+4% +$5.92K ﹤0.01% 1173
2014
Q1
$137K Sell
6,440
-92
-1% -$2.07K ﹤0.01% 1201
2013
Q4
$155K Hold
6,532
﹤0.01% 978
2013
Q3
$131K Hold
6,532
﹤0.01% 960
2013
Q2
$113K Buy
+6,532
New +$108K ﹤0.01% 927

Other funds holding TECH

Creative Planning's TECH Position: Q1 2026 in Review

Creative Planning increased its Bio-Techne (TECH) stake by 80% in Q1 2026, buying an estimated $2.34M and bringing the position to 87,773 shares worth $4.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1275.

Creative Planning first reported a position in TECH in Q2 2013 and has held it in 49 quarters since. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Creative Planning held 87,773 shares of Bio-Techne worth $4.59M as of Q1 2026.
  • Creative Planning bought 38,948 Bio-Techne shares in Q1 2026, an estimated $2.34M.
  • Bio-Techne made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1275 holding.
  • Creative Planning first reported a position in Bio-Techne in Q2 2013 and has held it in 49 quarters since.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.